Medetomidine, a Veterinary Sedative, Emerges in the U.S. Illegal Drug Market, CDC Reports
Recent reports from the Centers for Disease Control and Prevention (CDC) reveal a concerning rise in the presence of medetomidine, an animal sedative, within the United States' illegal drug supply. Initially used to sedate pets, medetomidine is chemically similar to xylazine, a drug known for its illicit use and complications in opioid overdoses. The drug was first identified in counterfeit opioids in North America in 2022, often mixed with fentanyl, the potent synthetic opioid responsible for a significant number of overdose deaths.
The CDC's recent publications focus on specific clusters of medetomidine-related cases in major cities such as Chicago, Philadelphia, and Pittsburgh. In Chicago, health officials detected 12 confirmed overdose cases involving medetomidine, with over 160 suspected or probable cases, including potential fatalities. Patients in these cases had ingested fentanyl, yet standard overdose reversal medication, naloxone, proved ineffective, indicating the presence of additional compounds like medetomidine.
Further investigations in Philadelphia uncovered medetomidine in 72% of tested illegal opioid samples, surpassing xylazine in prevalence and complicating ongoing efforts to combat the opioid crisis. These cases involved severe withdrawal symptoms resistant to typical medications used to treat fentanyl and xylazine overdoses. Interestingly, the drug dexmedetomidine, related to medetomidine, was found to be effective in managing some withdrawal cases.
Pittsburgh has reported similar occurrences, with ten cases documented during the same period. The rising prevalence of medetomidine underscores the evolving nature of the illicit drug market and highlights the need for increased vigilance and targeted interventions to address these emerging threats.
The CDC emphasizes the importance of monitoring these developments as they pose significant challenges to public health efforts aimed at reducing overdose fatalities and improving treatment outcomes.
For more detailed information, visit source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
How regional collaborations lower the cost of lifesaving medicines in developing nations
Regional collaborations through pooled procurement strategies significantly reduce the cost of essential medicines in developing countries, but they come with trade-offs like longer lead times and reduced flexibility. Learn how these approaches shape global health access.
Innovative Approach Uses Neutrophil Reprogramming to Combat Breast Cancer
A new study highlights how retraining neutrophils via innate immunity activation offers a promising therapeutic approach for difficult-to-treat breast cancers, including triple-negative subtypes.
Testosterone Gel Shows No Additional Benefits for Women Recovering from Hip Fractures, Study Finds
A recent clinical trial found that testosterone gel does not significantly improve overall recovery in women after hip fractures, highlighting the importance of exercise in rehabilitation efforts.